Videos Library
RWE: The good, the bad and the necessary
Related topics:
Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Global (non-specific)
Overview
- A review of success rates in recent drug launches.
- Look at where launches haven’t gone well and where RWE could have played a role in mitigating this: The bad.
- Building an Integrated Medical Plan to prepare for success (Begin with the end in mind): The good.
- The resource vs. demand challenge and the consequent benefit of outsourcing: The necessary.
Speaker
Alistair MacDonald
Executive Director, Real World Strategy
INC Research, UK
Subscribe or unlock this video to download the presentation slides. If you already have an account, please log in.
REMINDER
This is the presenters’ personal opinion and does not necessarily represent true facts, the official views or policy of their organisation, nor the views of Evidence Life Science.
Sponsor
